Top compounds associated with response to CDH10


Feature Type Standardized
Nominal ANOVA
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.017 0.6
mRNA L-685458 CCLE pan-cancer AAC -0.024 0.6
mRNA BRD-K19103580 CTRPv2 pan-cancer AAC -0.019 0.6
mRNA CAY10594 CTRPv2 pan-cancer AAC -0.019 0.6
mRNA MK-2206 CTRPv2 pan-cancer AAC -0.018 0.6
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.019 0.6
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.018 0.6
mRNA darinaparsin CTRPv2 pan-cancer AAC -0.025 0.6
mRNA NSC-207895 GDSC1000 pan-cancer AAC -0.017 0.6
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.017 0.6
Download CSV